Mycoplasma Pneumoniae Triggering the Guillain-Barre Syndrome
Ann Neurol 80:566-580, Meyer Sauteur, P.M.,et al, 2016
Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Guillain-Barre Syndrome
BMJ 337:227-231, Winer,J.B., 2008
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Campylobacter Gene Polymorphism as a Determinant of Clinical Features of Guillain-Barr Syndrome
Neurol 65:1376-1381,1350, Koga,M.,et al, 2005
Guillain-Barre Syndrome Seen in Users of Isotretinoin
BMJ 328:1537, Pritchard,J.,et al, 2004
Guillain-Barre Syndrome Following Acute Falciparum Malaria
Neurol 59:1281-1283, Sakrab,T.O.,et al, 2002
Guillain-Barre Syndrome
Lancet 352:635-641, Hahn,A.F., 1998
The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998
Cytomegalovirus Infection and Guillain-Barre Syndrome:The Clinical, Electrophysiologic, and Prognostic Features
Neurol 47:668-673, Visser,L.H.,et al, 1996
Campylobacter Jejuni Infection and Guillain-Barre Syndrome
NEJM 333:1374-1379, 14151995., Rees,J.H.,et al, 1995
The Spectrum of Immune Resp to C. Jejuni & Glycoconjugates in Guillain-Barre Synd Other Neuroimmunol Disorders
Ann Neurol 34:136-144, 1251993., Enders,U.,et al, 1993
Serologic Evidence of Previous Campylobacter Jejuni Infection in Patients with the Guillain-Barre Syndrome
Ann Int Med 118:947-953, Mishu,B.,et al, 1993
Elevated Serum Levels of Tumor Necrosis Factor-a in Guillain-Barre Syndrome
Ann Neurol 33:591-596, 5631993., Sharief,M.K.,et al, 1993
The Guillain-Barre Syndrome
NEJM 326:1130-1136, Ropper,A.H., 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
Serologic Evidence of Campylobacter Jejuni/coli Enteritis in Patients with Guillain-Barre Syndrome
Arch Neurol 48:1080-1082, Gruenewald,R.,et al, 1991
Clinical Signs in Severe Guillain-Barre Syndrome: Analysis of 63 Patients
J Neurol Sci 104:143-150, De Jager, A.E.J.,et al, 1991
A Prospective Study of Acute Idiopathic Neuropathy, II, Antecedent Events
JNNP 51:613-618, Winer,J.B.,et al, 1988
Campylobacter Diarrhea and Guillain-Barre Syndrome
Arch Neurol 45:655-656, Ropper,A.H., 1988
Immunologic Aspects of Neurological & Neuromuscular Diseases
JAMA 258:2970-2973, Zweiman,B.&Arnason,B.G.W., 1987
Streptokinase & the Guillain-Barre Syndrome
Ann Int Med 103:302, Arrowsmith,J.B.,et al, 1985
Guillaine-Barre Syndrome & Campylobacter Jejuni:A Serological Study
BMJ 288:1867-1870, Kaldor,J.,et al, 1984
Guillain-Barre Syndrome Associated with Campylobacter Infection
BMJ 285:173-174, Rhodes,K.M.,et al, 1982
Mycoplasma Antibody in Guillain-Barre Syndrome & Other Neurological Disorders
Ann Neurol 7:108-112, Goldschmidt,B.,et al, 1980
Cytomegalovirus Complement Fixation Antibody in Guillain-Barre Syndrome
Neurol 27:1153, Dowling,P.,et al, 1977
Gold Encephalopathy
JNNP 40:1021, McAuley,D.L.F.,et al, 1977
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
A 56-Year-Old Woman with New-Onset Hoarsement and Dysphagia
Neurol 104:e213363, McAree,M. & Frontera, J.A., 2025
Intracranial Hypertension Associated with Poly-Cranio-Radicular-Neuropathies A Case Report and Review of the Literature
Neurologist 29:166-169, Eaton,J.E.,et al, 2024
Expanding Clinical Spectrum an Anti-GQ1b Antibody Syndrome, A Review
JAMA Neurol 81:762-770, Lee,S-U.,et al, 2024
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
Ann Neurol 91:756-771, Frontera, J.A.,et al, 2022
An 8-Year-Old with Acute Onset Ataxia
Neurol 99:305-310, McLaren, J.R.,et al, 2022
Miller Fisher Syndrome and Acute Motor and Sensory Axonal Neuropathy (AMSAN) Variant Guillain-Barre Overlap Syndrome (MFS/AMSAN-GBS) After Upper Respiratory Tract Infection (URTI)
Acta Sci Clin Case Reports 3:19-24, Chau,T.C. & Muhamad,N.A.N., 2022
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome
JAMA Neurol 78:536-547, LaRovere, K.L.,et al, 2021
Complication of Hepatitis A Infection: Case Report of Acute Inflammatory Demyelinating Polyneuropathy
Clin Prac Case Emerg Med 5:113-116, Laursen,D.,et al, 2021
Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
Miller Fisher Syndrome and Polyneuritis Cranialis in COVID-19
Neurol 95:e601-e605, Gutierrez-Ortiz, C.,et al, 2020
A case of COVID-19-associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
Neurol 95:978-983, Liberatore, G.,et al, 2020
Guillain-Barre Syndrome Associated with SARS-CoV-2
NEJM 382:2574-2576, Tuscano, G.,et al, 2020
Guillain-Barre Syndrome Associated with JEV Infection
NEJM 383:1188-1190, Wang, G.,et al, 2020
Relapsing-Remitting Severe Bickerstaffs Brainstem Encephalitis
BMJ 394:684, Tyrakowska, Z.,et al, 2019
GQ1b-Seronegative Miller Fisher Syndrome Associated with Pembrolizumab
J Neuro-Ophthal 39:394-396, Green, K.E.,et al, 2019
A 35-year-old Woman with Diplopia, Ataxia, and Altered Mental Status
Neurol 91:e1942-e1946, Bauer, Z.,et al, 2018
Neuroimaging Findings of Zika Virus-Associated Neurologic Complications in Adults
AJNR 39:1967-1974, Hygino da Cruz, L.C.,et al, 2018
Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018
Acute Onset of Diplopia in Pregnancy
Neurol 91:e180-e184, Munro, Z. & Fernandez, D., 2018